1508:HKEXChina Reinsurance (Group) Corporation Analysis
Data as of 2026-09-02 - not real-time
HK$1.31
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind China Reinsurance (Group) Corporation is neutral at HKD 1.31, with no clear ordering between short and long averages. It has gained 3.1% over the past 30 days. With RSI at 60.5 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at HKD 1.18 and resistance at HKD 1.33.
The shares look undervalued, trading on 4.5 times earnings below a sector average of 16.7. Consensus targets land 26.8% above where the shares trade now. Revenue is growing at 6.9% on a 9.6% profit margin. The 6.23% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 36.5%, a beta of 0.15 and a maximum drawdown of 40.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
The shares look undervalued, trading on 4.5 times earnings below a sector average of 16.7. Consensus targets land 26.8% above where the shares trade now. Revenue is growing at 6.9% on a 9.6% profit margin. The 6.23% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 36.5%, a beta of 0.15 and a maximum drawdown of 40.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 1.45
- MACD momentum is positive
- Maximum drawdown of 40.4%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 4.5 versus sector average of 16.7
- Trading below the 200-day average of 1.45
- Analyst targets imply +26.8% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 4.5 versus sector average of 16.7
- Analyst targets imply +26.8% versus the current price
- Dividend yield of 6.23%
Key Metrics & Analysis
Financial Health
Revenue Growth6.90%
Profit Margin9.61%
P/E Ratio4.5
ROE9.37%
ROA1.93%
Debt/Equity61.85
P/B Ratio0.4
Op. Cash FlowHK$12.4B
Free Cash FlowHK$27.9B
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI60.5
SupportHK$1.18
ResistanceHK$1.33
MA 20HK$1.24
MA 50HK$1.23
MA 200HK$1.45
MACDBullish
VolumeIncreasing
Fear & Greed Index91.59
Valuation
Fair ValueHK$12.60
Target PriceHK$1.66
Upside/Downside26.83%
GradeUndervalued
TypeValue
Dividend Yield6.23%
Risk Assessment
Beta0.15
Volatility36.51%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.